Hartmans, Sybe
DSM Biotechnology Center,
Netherlands
2025 Rank: 218308
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Microbiology
Rank in SubField 1: 724 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 218308 | 240241 |
| Total Cites | 2826 | 3043 |
| H-index | 31 | 32 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 22 | 23 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 962 | 1048 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2173 | 2302 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2326 | 2439 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
7.13%
|
|
Hartmans, Sybe
DSM Biotechnology Center,
Netherlands
2024 Rank: 205579
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Microbiology
Rank in SubField 1: 667 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 205579 | 229259 |
| Total Cites | 2708 | 2924 |
| H-index | 31 | 31 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 22 | 23 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 921 | 1007 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2080 | 2208 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2223 | 2336 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
7.39%
|
|
Hartmans, Sybe
DSM Biotechnology Center,
Netherlands
2023 Rank: 195247
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Microbiology
Rank in SubField 1: 622 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 195247 | 215281 |
| Total Cites | 2612 | 2828 |
| H-index | 30 | 31 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 22 | 23 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 887 | 973 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2000 | 2128 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2135 | 2248 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
7.64%
|
|
Hartmans, Sybe
DSM Biotechnology Center,
Netherlands
2022 Rank: 186997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biotechnology
SubField 2:
Microbiology
Rank in SubField 1: 588 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 186997 | 204534 |
| Total Cites | 2513 | 2728 |
| H-index | 29 | 30 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 22 | 23 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 859 | 945 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1928 | 2056 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2043 | 2155 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
7.88%
|
|
Hartmans, Sybe
DSM Biotechnology Center,
Netherlands
2021 Rank: 180384
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Microbiology
Rank in SubField 1: 570 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 180384 | 197097 |
| Total Cites | 2455 | 2667 |
| H-index | 29 | 30 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 21 | 22 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 829 | 913 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1880 | 2006 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1998 | 2108 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
7.95%
|
|
Hartmans, Sybe
DSM Biotechnology Center,
Netherlands
2020 Rank: 167123
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Microbiology
Rank in SubField 1: 604 out of 50343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 167123 | 184977 |
| Total Cites | 2329 | 2541 |
| H-index | 28 | 29 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 20 | 21 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 783 | 868 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 1792 | 1919 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1886 | 1995 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
8.34%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.